Cargando…

S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA

BACKGROUND: Schizophrenia is thought to be a heterogeneous disorder and evidences reflect categorically distinct subtypes according to the antipsychotic treatment response. Altered frontostriatal functional connectivity (FC) in schizophrenia and its correlation with antipsychotic treatment response...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seoyoung, Jung, Wi Hoon, Kim, Euitae, Kwon, Jun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887982/
http://dx.doi.org/10.1093/schbul/sby018.943
_version_ 1783312428604325888
author Kim, Seoyoung
Jung, Wi Hoon
Kim, Euitae
Kwon, Jun Soo
author_facet Kim, Seoyoung
Jung, Wi Hoon
Kim, Euitae
Kwon, Jun Soo
author_sort Kim, Seoyoung
collection PubMed
description BACKGROUND: Schizophrenia is thought to be a heterogeneous disorder and evidences reflect categorically distinct subtypes according to the antipsychotic treatment response. Altered frontostriatal functional connectivity (FC) in schizophrenia and its correlation with antipsychotic treatment response also suggests divergence of underlying pathophysiologic mechanism. Meanwhile, the observations that prefrontal activity correlates with striatal dopaminergic function, leads to the hypothesis that the disrupted frontostriatal FC would be related with altered dopaminergic pathway in schizophrenia. The aim of this study was to investigate the relationship between frontostriatal FC and striatal dopaminergic activity in patients with schizophrenia according to the responsiveness to first-line antipsychotic drug. METHODS: 24 symptomatically stable schizophrenia patients were recruited from Seoul National University Hospital, 12 of which responded to first-line antipsychotic drugs (first-line AP group) and 12 stable under clozapine (clozapine group), along with 12 matched health controls. All participants underwent resting-state functional MRI and [F18]DOPA positron emission tomography. RESULTS: There were no significant difference in the total PANSS score between the first-line AP group and the clozapine group (mean difference=0.67, s.e.=3.21, df=33, p=1.000). Voxel-based analysis found significant negative correlation between frontal FC to the left associative striatum and the kicer in the corresponding region was found in first-line AP group but not in clozapine group or healthy control. Additional region of interest analysis confirmed the result (control group: R2=0.032, p=0.572; first-line AP group: R2=0.551, p=0.005; clozapine group: R2=0.108, p=0.297). DISCUSSION: Different patterns of relationship between striatal dopamine capacity and frontostriatal FC observed in this study indicates different pathophysiology underlying schizophrenia according to antipsychotics treatment-responsiveness. Results should be reconfirmed in prospective manner with larger sample size in future studies.
format Online
Article
Text
id pubmed-5887982
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58879822018-04-11 S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA Kim, Seoyoung Jung, Wi Hoon Kim, Euitae Kwon, Jun Soo Schizophr Bull Abstracts BACKGROUND: Schizophrenia is thought to be a heterogeneous disorder and evidences reflect categorically distinct subtypes according to the antipsychotic treatment response. Altered frontostriatal functional connectivity (FC) in schizophrenia and its correlation with antipsychotic treatment response also suggests divergence of underlying pathophysiologic mechanism. Meanwhile, the observations that prefrontal activity correlates with striatal dopaminergic function, leads to the hypothesis that the disrupted frontostriatal FC would be related with altered dopaminergic pathway in schizophrenia. The aim of this study was to investigate the relationship between frontostriatal FC and striatal dopaminergic activity in patients with schizophrenia according to the responsiveness to first-line antipsychotic drug. METHODS: 24 symptomatically stable schizophrenia patients were recruited from Seoul National University Hospital, 12 of which responded to first-line antipsychotic drugs (first-line AP group) and 12 stable under clozapine (clozapine group), along with 12 matched health controls. All participants underwent resting-state functional MRI and [F18]DOPA positron emission tomography. RESULTS: There were no significant difference in the total PANSS score between the first-line AP group and the clozapine group (mean difference=0.67, s.e.=3.21, df=33, p=1.000). Voxel-based analysis found significant negative correlation between frontal FC to the left associative striatum and the kicer in the corresponding region was found in first-line AP group but not in clozapine group or healthy control. Additional region of interest analysis confirmed the result (control group: R2=0.032, p=0.572; first-line AP group: R2=0.551, p=0.005; clozapine group: R2=0.108, p=0.297). DISCUSSION: Different patterns of relationship between striatal dopamine capacity and frontostriatal FC observed in this study indicates different pathophysiology underlying schizophrenia according to antipsychotics treatment-responsiveness. Results should be reconfirmed in prospective manner with larger sample size in future studies. Oxford University Press 2018-04 2018-04-01 /pmc/articles/PMC5887982/ http://dx.doi.org/10.1093/schbul/sby018.943 Text en © Maryland Psychiatric Research Center 2018. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Kim, Seoyoung
Jung, Wi Hoon
Kim, Euitae
Kwon, Jun Soo
S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
title S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
title_full S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
title_fullStr S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
title_full_unstemmed S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
title_short S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
title_sort s156. fronto-striatal functional connectivity and striatal dopamine capacity in treatment-responsive and refractory schizophrenia
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887982/
http://dx.doi.org/10.1093/schbul/sby018.943
work_keys_str_mv AT kimseoyoung s156frontostriatalfunctionalconnectivityandstriataldopaminecapacityintreatmentresponsiveandrefractoryschizophrenia
AT jungwihoon s156frontostriatalfunctionalconnectivityandstriataldopaminecapacityintreatmentresponsiveandrefractoryschizophrenia
AT kimeuitae s156frontostriatalfunctionalconnectivityandstriataldopaminecapacityintreatmentresponsiveandrefractoryschizophrenia
AT kwonjunsoo s156frontostriatalfunctionalconnectivityandstriataldopaminecapacityintreatmentresponsiveandrefractoryschizophrenia